VERVVerve Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsMay 14
Mkt Cap$993.66M
Vol10.31M

About

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
274

Frequently Asked Questions

What is Market Cap of Verve Therapeutics Inc?
What is the 52-week high for Verve Therapeutics Inc?
What is the 52-week low for Verve Therapeutics Inc?
What is Verve Therapeutics Inc stock price today?
What was Verve Therapeutics Inc stock price yesterday?
What is the PE ratio of Verve Therapeutics Inc?
What is the Price-to-Book ratio of Verve Therapeutics Inc?
What is the 50-day moving average of Verve Therapeutics Inc?
How many employees does Verve Therapeutics Inc have?

Advertisement|Remove ads.